Literature DB >> 25689086

Expression of a metalloproteinase family of ADAMTS in human vulnerable carotid lesions.

Jaroslav Pelisek1, Lena Deutsch, Anna Ansel, Julia Pongratz, Thomas Stadlbauer, Harry Gebhard, Edouard Matevossian, Hans-Henning Eckstein.   

Abstract

AIMS: ADAMTS family of metalloproteases (a disintegrin and metalloprotease with thrombospondin motifs) possesses high proteolytic activity especially regarding proteoglycans. Their expression pattern in carotid plaques is as-yet unknown. The aim of the study was therefore the analysis of expression of ADAMTS1, 4, 5, and 13 and their inhibitors TIMP-1 and TIMP-3 in stable and unstable carotid plaques.
METHODS: Atherosclerotic plaques were collected from 40 patients (29 men, 11 women, mean age 70 years) undergoing carotid endarterectomy. The specimens were categorized into two groups (stable/unstable) according to Redgrave und Rothwell (The Oxford Plaque Study, 2008). SYBR Green-based real-time PCR, histology, and immunohistochemistry were performed.
RESULTS: All ADAMTS tested in our study were expressed in both stable and unstable plaques, especially in smooth muscle cells (SMCs) and macrophages. Analysis of the expression pattern on mRNA level showed significant higher expression of ADAMTS1 in unstable plaques compared with stable plaques (1.7-fold, P = 0.049). The expression of ADAMTS4 and 5 was also increased in unstable lesions; however, these changes were not statistically significant (1.2-fold, P = 0.667 and 1.6-fold, P = 0.077). Expression of TIMP-1 was significantly reduced in unstable plaques compared with stable ones (1.9-fold, P = 0.014).
CONCLUSION: SMCs seem to be an important source of ADAMTS analyzed in our study. Furthermore, expression of ADAMTS1 was found to be increased in unstable carotid lesions and might potentially contribute to plaque vulnerability.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 25689086     DOI: 10.2459/JCM.0000000000000254

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  5 in total

Review 1.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

2.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

3.  ADAMTS proteases in cardiovascular physiology and disease.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Open Biol       Date:  2020-12-23       Impact factor: 6.411

4.  The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease.

Authors:  J A F Demandt; L J Dubois; K van Kuijk; M Zaťovičová; H Jin; S Parkkila; S W van der Laan; L Jelenska; B M E Mees; C P M Reutelingsperger; K B J M Cleutjens; C J H van der Kallen; C G Schalkwijk; M M J van Greevenbroek; E A L Biessen; G Pasterkamp; S Pastoreková; C D A Stehouwer; J C Sluimer
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

Review 5.  Identification Markers of Carotid Vulnerable Plaques: An Update.

Authors:  Yilin Wang; Tao Wang; Yumin Luo; Liqun Jiao
Journal:  Biomolecules       Date:  2022-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.